ALKS vs EMN · P/E 14, rev $1.56B vs P/E 21, rev $9.38B
Alkermes Plc (ALKS) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the ALKS and EMN stock pages for the full models.
Not investment advice.